| Serial Number | 88925510 |
| Word Mark | AIVIVA BIOPHARMA |
| Filing Date | Wednesday, May 20, 2020 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, November 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, April 12, 2022 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOPHARMA" |
| Goods and Services | Conducting clinical trials for others; Conducting of feasibility studies in the field of new technologies; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Conducting scientific feasibility studies; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Research and development and consultation related thereto in the field of pharmaceutical research and development; Research and development in the field of skin disorders, eye related disorder, cancer and prostate related disorder; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Research in the field of pharmaceuticals; Research on the subject of pharmaceuticals; Scientific study and research in the field(s) of treatment and management of illness; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff |
| Description of Mark | The mark consists of the word "AIVIVA" having an extended downward line on the first letter "A" and a an extended upward line on the first "V" above the word "BioPharma". |
| Goods and Services | Anti-dermoinfectives; Anti-friction skin preparations for preventing blisters; Anti-friction skin preparations for preventing chafing; Antibacterial alcohol skin sanitizer gel; Antimicrobials for dermatologic use; Bandages for skin wounds; Dermatological pharmaceutical products; Gels, creams and solutions for dermatological use; Medical cleansers for skin and wounds; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicaments for treating skin disorders, cancer and prostate related disorder; Medicated balms for treatment of skin; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated lotions for skin; Medicated ointments for treating dermatological conditions; Medicated skin preparation for use in treating aberrant wound healing and skin cancer; Non-medicated, therapeutic skin creams for the treatment of aberrant wound healing and skin cancer; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for skin care for animals; Preparations for cleansing the skin for medical use; Processed human donor skin for the replacement of soft tissue; Skin grafts; Topical dermatological preparations that treat insect bites and stings |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 4, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, May 6, 2024 |
| First Use In Commerce Date | Monday, May 6, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 4, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, May 6, 2024 |
| First Use In Commerce Date | Monday, May 6, 2024 |
| Party Name | AiViva Biopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Dover, DE 19904 |
| Party Name | AiViva Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dover, DE 19904 |
| Event Date | Event Description |
| Saturday, May 23, 2020 | NEW APPLICATION ENTERED |
| Thursday, June 4, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 19, 2020 | ASSIGNED TO EXAMINER |
| Thursday, August 20, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, August 20, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, August 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 4, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 4, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 4, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 3, 2020 | SUSPENSION LETTER WRITTEN |
| Thursday, December 3, 2020 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 3, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, August 23, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, September 27, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, September 27, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, September 27, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 19, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 9, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 9, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 9, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 9, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 12, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, May 9, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Sunday, August 21, 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, October 4, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 13, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 3, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 3, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 3, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 9, 2023 | SOU EXTENSION 1 FILED |
| Monday, January 9, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, January 11, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 28, 2023 | SOU EXTENSION 2 FILED |
| Thursday, September 28, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, September 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 29, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 10, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 10, 2023 | ITU LETTER MAILED, NO RESPONSE REQUIRED |
| Friday, March 29, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 29, 2024 | SOU EXTENSION 3 FILED |
| Friday, March 29, 2024 | SOU EXTENSION 3 GRANTED |
| Saturday, March 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, September 16, 2024 | SOU EXTENSION 4 FILED |
| Monday, September 16, 2024 | SOU EXTENSION 4 GRANTED |
| Monday, September 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 1, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 1, 2025 | SOU EXTENSION 5 FILED |
| Tuesday, September 16, 2025 | SOU EXTENSION 5 GRANTED |
| Tuesday, September 16, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 17, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, November 13, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, September 17, 2025 | USE AMENDMENT FILED |
| Thursday, November 20, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, November 20, 2025 | SU - NON-FINAL ACTION - WRITTEN |
| Thursday, November 20, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, November 20, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |